Comparing The Effect Of The SGLT-2 Inhibitors And DPP-4 Inhibitor Combined Therapy With Sulphonylureas And Metformin Combined Therapy In Patients With Type 2 Diabetic Nephropathy. Journal of Pharmaceutical Negative Results, [S. l.], p. 498–502, 2023. DOI: 10.47750/pnr.2023.14.04.59. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/10444.. Acesso em: 4 jun. 2026.